WEB EXCLUSIVES
Ambulatory Resource Utilization and Cost for Gout in United States
Chenghui Li, PhD; Bradley C. Martin, PharmD, PhD; Dosha F. Cummins, PharmD; L. Mon Andrews, MPH; Feride Frech-Tamas, PhD; and Anthony M. Yadao, MD
Using nationally representative survey databases, this study described ambulatory care utilization and costs for gout, and examined patient characteristics associated with gout-related visits.
2013 Volume 5 Number 2
Cost-Effectiveness of 3 Statin Sample Policies in Post-Myocardial Infarction Patients
Rola Kaakeh, PharmD, CFPH; David W. Hutton, PhD; Kylee Funk, PharmD; Justin Gatwood, MPH; Bernadette Chan, PharmD; and Maha Salah-Ud-Din, BS
Providing generic samples was the dominant strategy among 3 statin sample policies, indicating that use of generic samples should be increased.
2013 Volume 5 Number 2
Costs of Treatment and Clinical Events for Secondary Hyperparathyroidism
Andrew Lee, PhD; Vasily Belozeroff, PhD; Xue Song, PhD; David Diakun, BS; and William Goodman, MD
End-stage renal disease patients with secondary hyperparathyroidism have high costs of care and a substantial quality-of-life burden.
2013 Volume 5 Number 2
Computed Tomography Scan Use Variation: Patient, Hospital, and Geographic Factors
Eric A. Vance, PhD; Xiaojin Xie, MS; Andrew Henry, BS; Christian Wernz, PhD; and Anthony D. Slonim, MD, DrPH
We observed small-area variation in computed tomography scan use for inpatients in New York State, even after controlling for relevant patient and hospital characteristics.
2013 Volume 19 Number 3
Low Clinical Utility of Folate Determinations in Primary Care Setting
Shlomo Vinker, MD; Eli Krantman, MD; Michal Shani, MD; and Sasson Nakar, MD
It seems that folate determinations in patients without known risk factors for folate deficiency are of little clinical significance.
2013 Volume 19 Number 3
Trends in Inpatient Hospital Prices, 2008 to 2010
Jeff Lemieux, MA; and Teresa Mulligan, MHSA
A comprehensive presentation of intensity-adjusted hospital price levels and growth rates, including national detail on more than 350 types of hospitalizations, and regional and local averages.
2013 Volume 19 Number 3
Factors Associated With Primary Hip Arthroplasty After Hip Fracture
Ishveen Chopra, MS; Khalid M. Kamal, PhD; Jayashri Sankaranarayanan, MPharm, PhD; and Gibbs Kanyongo, PhD
Patient, clinical, and hospital factors were associated with receiving primary hip arthroplasty versus no surgery after hip fracture in the United States.
2013 Volume 19 Number 3
Measuring Concurrent Oral Hypoglycemic and Antidepressant Adherence and Clinical Outcomes
Hillary R. Bogner, MD, MSCE; Heather F. de Vries, MSPH; Alison J. O’Donnell, BA; and Knashawn H. Morales, ScD
Self-reported adherence tended to overestimate medication adherence compared with electronic monitoring. Electronic monitoring of oral hypoglycemic agents but not self-reported adherence predicted glycemic control.
2013 Volume 19 Number 3
The Cost of Implementing Inpatient Bar Code Medication Administration
Julie Ann Sakowski, PhD; and Alana Ketchel, MPP, MPH
Bar code medication administration can be an effective and potentially cost-saving solution to prevent harmful medication administration errors in the community hospital setting.
2013 Volume 19 Number 2
Spending and Mortality in US Acute Care Hospitals
John A. Romley, PhD; Anupam B. Jena, MD, PhD; June F. O’Leary, PhD; and Dana P. Goldman, PhD
Across the US, adults with major medical conditions were less likely to die in hospitals with higher spending levels, even after adjusting for patient risk.
2013 Volume 19 Number 2